We found that PPARγ in the benign breast disease showed positive immunoreactivity mostly in the nucleus (Figure 1A), while ER-negative breast carcinoma samples (poorly differentiated) displayed cytoplasmic mainly staining (Figure 1B). Here, PPARG is linked to breast carcinoma.